A functionally improved case of obstructive impairment caused by systemic lupus erythematosus
Copyright ©ERS 2021..
Pulmonary lymphoproliferative diseases are often associated with collagen diseases. In addition to treatment of the primary disease, additional treatments may be considered depending on the pathology presented in the case. https://bit.ly/3vKqsls.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
|---|---|
| Enthalten in: |
Breathe (Sheffield, England) - 17(2021), 2 vom: 21. Juni, Seite 200288 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kamimaki, Chisato [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 24.07.2021 published: Print Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1183/20734735.0288-2020 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM328403407 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM328403407 | ||
| 003 | DE-627 | ||
| 005 | 20231225202850.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1183/20734735.0288-2020 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1094.xml |
| 035 | |a (DE-627)NLM328403407 | ||
| 035 | |a (NLM)34295418 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kamimaki, Chisato |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A functionally improved case of obstructive impairment caused by systemic lupus erythematosus |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 24.07.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright ©ERS 2021. | ||
| 520 | |a Pulmonary lymphoproliferative diseases are often associated with collagen diseases. In addition to treatment of the primary disease, additional treatments may be considered depending on the pathology presented in the case. https://bit.ly/3vKqsls | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Yamamoto, Masaki |e verfasserin |4 aut | |
| 700 | 1 | |a Sawazumi, Tomoe |e verfasserin |4 aut | |
| 700 | 1 | |a Kudo, Makoto |e verfasserin |4 aut | |
| 700 | 1 | |a Kaneko, Takeshi |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Breathe (Sheffield, England) |d 2014 |g 17(2021), 2 vom: 21. Juni, Seite 200288 |w (DE-627)NLM25214855X |x 1810-6838 |7 nnns |
| 773 | 1 | 8 | |g volume:17 |g year:2021 |g number:2 |g day:21 |g month:06 |g pages:200288 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1183/20734735.0288-2020 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 17 |j 2021 |e 2 |b 21 |c 06 |h 200288 | ||